TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $3.06 billion. The enterprise value is $3.44 billion.
| Market Cap | 3.06B |
| Enterprise Value | 3.44B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.73 million shares outstanding. The number of shares has decreased by -4.65% in one year.
| Current Share Class | 34.68M |
| Shares Outstanding | 34.73M |
| Shares Change (YoY) | -4.65% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 3.18% |
| Owned by Institutions (%) | 101.45% |
| Float | 33.56M |
Valuation Ratios
The trailing PE ratio is 22.77 and the forward PE ratio is 43.68. TMDX's PEG ratio is 0.87.
| PE Ratio | 22.77 |
| Forward PE | 43.68 |
| PS Ratio | 4.21 |
| Forward PS | 3.66 |
| PB Ratio | 5.56 |
| P/TBV Ratio | 5.78 |
| P/FCF Ratio | 68.57 |
| P/OCF Ratio | 27.28 |
| PEG Ratio | 0.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.76, with an EV/FCF ratio of 76.94.
| EV / Earnings | 23.81 |
| EV / Sales | 4.73 |
| EV / EBITDA | 27.76 |
| EV / EBIT | 39.78 |
| EV / FCF | 76.94 |
Financial Position
The company has a current ratio of 4.53, with a Debt / Equity ratio of 1.57.
| Current Ratio | 4.53 |
| Quick Ratio | 3.98 |
| Debt / Equity | 1.57 |
| Debt / EBITDA | 6.53 |
| Debt / FCF | 19.40 |
| Interest Coverage | 3.46 |
Financial Efficiency
Return on equity (ROE) is 31.89% and return on invested capital (ROIC) is 9.41%.
| Return on Equity (ROE) | 31.89% |
| Return on Assets (ROA) | 4.39% |
| Return on Invested Capital (ROIC) | 9.41% |
| Return on Capital Employed (ROCE) | 6.33% |
| Weighted Average Cost of Capital (WACC) | 12.80% |
| Revenue Per Employee | $810,301 |
| Profits Per Employee | $160,861 |
| Employee Count | 898 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 5.62 |
Taxes
| Income Tax | -70.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.10% in the last 52 weeks. The beta is 2.10, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | -29.10% |
| 50-Day Moving Average | 79.62 |
| 200-Day Moving Average | 92.80 |
| Relative Strength Index (RSI) | 66.55 |
| Average Volume (20 Days) | 1,140,458 |
Short Selling Information
The latest short interest is 8.77 million, so 25.25% of the outstanding shares have been sold short.
| Short Interest | 8.77M |
| Short Previous Month | 8.55M |
| Short % of Shares Out | 25.25% |
| Short % of Float | 26.13% |
| Short Ratio (days to cover) | 11.14 |
Income Statement
In the last 12 months, TMDX had revenue of $727.65 million and earned $144.45 million in profits. Earnings per share was $3.88.
| Revenue | 727.65M |
| Gross Profit | 426.43M |
| Operating Income | 86.45M |
| Pretax Income | 73.62M |
| Net Income | 144.45M |
| EBITDA | 123.86M |
| EBIT | 86.45M |
| Earnings Per Share (EPS) | $3.88 |
Balance Sheet
The company has $492.96 million in cash and $866.90 million in debt, with a net cash position of -$373.94 million or -$10.77 per share.
| Cash & Cash Equivalents | 492.96M |
| Total Debt | 866.90M |
| Net Cash | -373.94M |
| Net Cash Per Share | -$10.77 |
| Equity (Book Value) | 550.71M |
| Book Value Per Share | 15.86 |
| Working Capital | 539.60M |
Cash Flow
In the last 12 months, operating cash flow was $112.36 million and capital expenditures -$67.66 million, giving a free cash flow of $44.70 million.
| Operating Cash Flow | 112.36M |
| Capital Expenditures | -67.66M |
| Depreciation & Amortization | 37.41M |
| Net Borrowing | -5.00M |
| Free Cash Flow | 44.70M |
| FCF Per Share | $1.29 |
Margins
Gross margin is 58.60%, with operating and profit margins of 11.88% and 19.85%.
| Gross Margin | 58.60% |
| Operating Margin | 11.88% |
| Pretax Margin | 10.12% |
| Profit Margin | 19.85% |
| EBITDA Margin | 17.02% |
| EBIT Margin | 11.88% |
| FCF Margin | 6.14% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.65% |
| Shareholder Yield | 4.65% |
| Earnings Yield | 4.39% |
| FCF Yield | 1.46% |
Analyst Forecast
The average price target for TMDX is $99.18, which is 12.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $99.18 |
| Price Target Difference | 12.40% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 18.92% |
| EPS Growth Forecast (3Y) | 7.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 3.12 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 4 |